Magellan Rx Management Oncology Biosimilar Solution Delivers $40M+ in Annualized Savings for Early Adopter Health Plans

×

Error message

  • Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

Magellan Rx Management , a division of Magellan Health, Inc. (NASDAQ: MGLN), today announced annualized savings of over $40 million for five health plan customers who were early adopters of its oncology biosimilar medical benefit drug management solution .